MedTech Navigator Reverse Pitch Series: Medtronic
Event Description
Join MedTech Navigator for an exclusive reverse pitch session featuring Medtronic, one of the world's leading medical technology companies.
Unlike a traditional pitch event, this session puts the spotlight on Medtronic, providing Australian MedTech companies with direct insight into the company's strategic priorities, procurement needs, supply chain challenges, and partnership opportunities. Participants will hear firsthand what Medtronic looks for in potential collaborators and gain practical guidance on engaging with a global MedTech leader.
The session will conclude with an interactive Q&A and short company introductions, providing attendees with an opportunity to showcase their capabilities and identify potential areas of alignment.
Key Takeaways
Attendees will:
- Gain insight into Medtronic's current strategic, procurement and supply chain priorities.
- Understand the challenges and opportunities where external partners can add value.
- Learn what global MedTech companies look for in prospective collaborators, suppliers and innovation partners.
- Better understand expectations around capability, commercial readiness and regulatory requirements.
- Receive practical guidance on how to effectively approach and engage with multinational MedTech organisations.
- Build awareness of potential pathways for international partnerships, market access and supply chain integration.
Target Audience
This session is designed for Australian MedTech companies, including:
- Medical device, diagnostic and digital health (including SaMD) innovators.
- Early-stage startups, researchers and spinouts progressing towards commercialisation.
- Growth-stage and established SMEs seeking partnership opportunities with multinational companies.
- Organisations interested in international market expansion, procurement pathways, strategic partnerships and supply chain integration.
- Participants in the MedTech Navigator program and the broader Australian MedTech ecosystem.
Recommended for: Founders, CEOs, business development leaders, commercialisation managers, innovation leads and industry engagement professionals.
Find out more about MedTech Navigator here: https://medtechcompass.org.au/navigator/
MedTech Navigator is delivered in collaboration with the Australian Trade and Investment Commission, Austrade.
The Trade Diversification Network has been set up to deliver the Accessing New Markets Initiative, bringing together national peak industry bodies representing Australian exporters.
By combining MTAA’s industry connections with Austrade’s international trade expertise and networks, MedTech Navigator helps Australian companies better understand and prepare for opportunities in global markets.
Please note: This webinar will be recorded and may be shared in the future at the discretion of the MTAA and that by registering for this event you agree to MTAA's Terms and Conditions and MTAA's Privacy Policy.
Contact Information
Additional Information
Your Speakers
Philia Hiotis is Vice President, Strategy & Business Development at Medtronic, where she leads strategic growth initiatives, partnerships, and market expansion across the company’s global portfolio.
With extensive experience in the medical technology sector, Philia has a strong track record in corporate strategy, commercialisation, and building high-impact collaborations between industry, healthcare systems, and innovation ecosystems. Her work focuses on identifying emerging opportunities, advancing access to new technologies, and strengthening Medtronic’s engagement with external partners, including startups, SMEs, and research organisations.
Philia brings a global perspective on MedTech innovation and is particularly focused on how large-scale healthcare companies can work more effectively with smaller innovators to accelerate development, adoption, and patient impact.
As Innovation & Growth Lead at the Medical Technology Association of Australia (MTAA), I work at the intersection of industry, capital and policy to strengthen and scale Australia’s Medtech ecosystem. My focus is on unlocking growth pathways for medical technology companies, from early-stage innovation through to global expansion, and ensuring the right investment, regulatory and commercial settings exist for success. Medtech is not just my sector - it’s my expertise. I bring deep knowledge across innovation pipelines, capital strategy, reimbursement, regulation and commercialisation. I’m passionate about translating complex industry issues into clear, strategic conversations that drive outcomes for patients, companies and the broader healthcare system.
